SCHEMBL22829216

SCHEMBL22829216

O=C(NCc1ccc(-c2cccc(C(O)(C(=O)O)c3ccccc3)c2)o1)c1ccc(CNCC(O)c2ccc(O)c3[nH]c(=O)ccc23)cc1

nearest known ligand 0.69

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ADRB2 P07550 20/20 0.69
▸ CHRM3 P20309 17/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22829213 1.00 ADRB2 (0.69) ADRB2CHRM3
SCHEMBL22829075 0.88 ADRB2 (0.75) ADRB2CHRM3
SCHEMBL22829074 0.88 ADRB2 (0.75) ADRB2CHRM3
SCHEMBL22829090 0.87 ADRB2 (0.69) ADRB2CHRM3
SCHEMBL22829092 0.87 ADRB2 (0.69) ADRB2CHRM3
SCHEMBL22829127 0.87 ADRB2 (0.68) ADRB2CHRM3
SCHEMBL22829125 0.87 ADRB2 (0.68) ADRB2CHRM3
SCHEMBL22829207 0.87 ADRB2 (0.69) ADRB2CHRM3
SCHEMBL22829210 0.87 ADRB2 (0.69) ADRB2CHRM3
SCHEMBL22829077 0.87 ADRB2 (0.71) ADRB2CHRM3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3484879-B1 HYDROXYQUINOLINONE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARM SPA (IT) 2020-12-30 — — EP claimed
EP-3484879-B1 HYDROXYQUINOLINONE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARM SPA (IT) 2020-12-30 — — EP disclosed
Send feedback